Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
17.53
+0.75 (4.47%)
At close: Jun 18, 2026, 4:00 PM EDT
17.70
+0.17 (0.97%)
After-hours: Jun 18, 2026, 7:50 PM EDT
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Adaptive Biotechnologies stock has a consensus rating of "Buy" and an average price target of $20.14. The average 1-year stock price forecast is 14.89% higher than the current stock price, while the lowest is $18 (+2.68%) and the highest is $22 (+25.50%).
Price Target: $20.14 (+14.89%)
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 16, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $18 | Hold | Maintains | $21 → $18 | +2.68% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +14.09% | May 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $21 → $19 | Buy | Reiterates | $21 → $19 | +8.39% | May 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $21 | Buy | Reiterates | $21 | +19.79% | May 6, 2026 |
Financial Forecast
Revenue This Year
287.25M
from 276.98M
Increased by 3.71%
Revenue Next Year
352.11M
from 287.25M
Increased by 22.58%
EPS This Year
-0.46
from -0.39
EPS Next Year
-0.25
from -0.46
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 290.4M | ||
| Avg | 287.2M | ||
| Low | 284.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.8% | ||
| Avg | 3.7% | ||
| Low | 2.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.43 | ||
| Avg | -0.46 | ||
| Low | -0.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |